MHR Fund Management LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), MHR Fund Management LLC reported 9 stock positions worth $904.4 million. Its top holding was Telesat (TSAT) at 32.8% of the portfolio, followed by Iovance Biotherapeutics (IOVA, 20.0%) and Lions Gate Entmnt (19.0%). Compared with Q3 2024, it opened 2 new positions, sold out of 2, added to 1 and reduced 1. The biggest buy was a new position in Hafnia (HAFN) and the biggest sale an exit from Titan International (TWI).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001277742
- Portfolio Value
- $904.4M (Q4 2024)
- SEC Filing
- 0001011438-25-000177 ↗ filed Feb 14, 2025
Holdings Value
Holdings 9 stocks · $904.4M
| TSAT Telesat Corp. | 32.78% | 18,035,092 | $296.5M | No change |
| IOVA Iovance Biotherapeutics Inc. | 19.98% | 24,417,103 | $180.7M | Add +1.8% |
| LIONS GATE ENTMNT CORP | 19.01% | 20,127,661 | $171.9M | No change |
| LGF.B Lions Gate Entertainment-B | 12.61% | 15,105,523 | $114.0M | No change |
| APO Apollo Global Management Inc. | 10.04% | 550,000 | $90.8M | Reduce -19.0% |
| HAFN Hafnia Ltd. | 4.69% | 7,620,781 | $42.4M | New |
| GEO The Geo Group Inc. | 0.77% | 250,000 | $7.0M | New |
| DVAX Dynavax Technologies Corp. | 0.06% | 44,499 | $568K | No change |
| OPTU Optimum Communications Inc. Class A filed as ALTICE USA INC | 0.04% | 167,800 | $404K | No change |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $1.9B | TSAT, LION, HAFN, IOVA, STRZ |
| Q1 2026 | 10 | $1.4B | TSAT, LION, HAFN, IOVA, APO |
| Q4 2025 | 10 | $1.2B | TSAT, LION, HAFN, IOVA, APO |
| Q3 2025 | 10 | $1.0B | TSAT, LION, HAFN, IOVA, APO |
| Q2 2025 | 9 | $901.6M | TSAT, LION, HAFN, APO, IOVA |
| Q1 2025 | 9 | $832.0M | TSAT, LIONS GATE ENTMNT CORP, LGF.B, IOVA, APO |
| Q4 2024 | 9 | $904.4M | TSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO |
| Q3 2024 | 9 | $917.0M | TSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO |
| Q2 2024 | 9 | $820.6M | IOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, APO |
| Q1 2024 | 10 | $1.0B | IOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, TWI |